OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
September 11, 2020
The FDA issued a safety alert about efficacy and potential safety concerns with a combination therapy being studied for the treatment of breast cancer.
September 10, 2020
Oncology pharmacists have implemented new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens during the pandemic.
September 03, 2020
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to a major new study.
Oral azacitidine (Onureg; Celgene) is approved for patients in first remission with acute myeloid leukeimia.
August 19, 2020
Oncology medical and infusion services have declined since the start of COVID-19.
August 13, 2020
Results from the study showed antitumor activity and safety to be similar to olaparib and durvalumab monotherapy study findings.
August 12, 2020
Pharmacists should counsel patients on how taking steps now can prevent certain cancers later.
August 07, 2020
The advent of generic and biosimilar medicines for novel treatments has helped bridge the gap in the delivery of cancer care between the United States and India, according to the study.
August 06, 2020
ESMO released changes to its recommendations on how to manage patients with cancer during the COVID-19 pandemic.
August 03, 2020
A recent study evaluated the effects of the COVID-19 pandemic on normal cancer care activities, including cancer screening efforts.
July 21, 2020
Karyopharm announced that the agency has accepted for filing its supplemental New Drug Application for selinexor as a second-line treatment for multiple myeloma.
July 15, 2020
A recent study found that the programs may result in cost savings to health systems and patients.
July 01, 2020
The fixed-dose combination of pertuzumab and trastuzumab with hyaluronidase (Phesgo; Genentech) can be administered subcutaneously for patients with HER2-positive breast cancer.
June 26, 2020
Today, pharmacists are banding together to “eliminate racism, discrimination, injustice, and the marginalization of individuals within the profession.”
June 11, 2020
An exploratory analysis of 2 phase 3 trials evaluating ribociclib (Kisqali, Novartis) plus endocrine therapy in advanced breast cancer showed positive results.
June 10, 2020
Oncology pharmacy practitioners highlight challenges amid the pandemic, such as limited access to personal protective equipment and essential medications.
June 08, 2020
The study, presented at the virtual ASCO20, showed significant clinical benefit for patients with endometrial cancer who were treated with cabozantinib and nivolumab.
June 01, 2020
Officials with the FDA approved atezolizumab (Tecentriq, Genentech) in combination with bevacizumab (Avastin) for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.
May 30, 2020
A systematic review of medical cannabis and cannabinoid use in oncology care demonstrated varied results.
Targeted therapy osimertinib (Tagrisso) demonstrated significant improvements in disease-free survival in patients with localized non-small cell lung cancer (NSCLC) who were treated following surgery.